Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
Open Access
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 21 (4) , 701-706
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
- National Cancer Institute
- Office of Naval Research (N00014-06-1-0704, N00014-08-1-0058)
- Allos
- Amgen
- Angioblast
This publication has 17 references indexed in Scilit:
- Older Patients with Myeloma Derive Similar Benefit from Autologous TransplantationTransplantation and Cellular Therapy, 2014
- Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician WorkforceTransplantation and Cellular Therapy, 2009
- Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysisAmerican Journal of Hematology, 2008
- Recent major improvement in long-term survival of younger patients with multiple myelomaBlood, 2008
- Lifetime Probabilities of Hematopoietic Stem Cell Transplantation in the U.S.Transplantation and Cellular Therapy, 2008
- Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trialThe Lancet, 2007
- Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003Journal of Clinical Oncology, 2007
- Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trialBlood, 2004
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996